Animal models of Huntington's disease. Pros and cons
Brain, Behavior, & Immunity - Health · 2025-12 · 50 · 101149
DOI: 10.1016/j.bbih.2025.101149 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain, Behavior, & Immunity - Health, 2025-12. Verfasst von Polina Stepanova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, University of Helsinki, Helsinki, Finland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suomen Kulttuurirahasto, Medical Association of Life and Health, Finska Läkaresällskapet.
Abstract (Originalsprache)
Modelling of human neurological diseases uses a plethora of ever-more sophisticated methods and approaches. For Huntington's disease (HD), which affects specific neuronal types and circuits in the brain, this has meant the use of both neurotoxic compounds and various animal models of different complexity, ranging from rodents to non-primate ones. Genetic models are classified based on the use of specific constructs including gene including gene fragments, full-length, knock-out and knock-in models. In this review, we will discuss the available animal models for HD, highlighting their pros and cons in studying the neuropathology, behavioural alterations, and biological mechanisms that prevail in HD and during the disease progression. We also highlight present knowledge gaps and difficulties to fully recapitulate the human disease. At the end we will further elaborate on current outstanding questions in HD research that warrant further studies using both animal models and patient data. This may help to guide future research and increase the translational relevance of the models to solve key questions and pave the way for better treatment options and design of drugs to alleviate the course of HD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
- Medicum, Department of Biochemistry and Developmental Biology, Medical Faculty, POB 63, FIN-00014, University of Helsinki, Finland.
- Minerva Foundation Institute for Medical Research, Biomedicum-2, Tukholmankatu 8, FIN-00290, Helsinki, Finland.
- Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Förderung
- Suomen Kulttuurirahasto
- Medical Association of Life and Health
- Finska Läkaresällskapet
- Hjärnfonden
- Suomen Parkinson-säätiö
- Magnus Ehrnroothin Säätiö
- Jane ja Aatos Erkon Säätiö
- Suomen Tiedeseura
Zitieren
APA
Stepanova, P., Voutilainen, M. H., Eriksson, O., & Lindholm, D. (2025). Animal models of Huntington's disease. Pros and cons. Brain, Behavior, & Immunity - Health, 50, 101149. https://doi.org/10.1016/j.bbih.2025.101149
Vancouver
Stepanova P, Voutilainen MH, Eriksson O, Lindholm D. Animal models of Huntington's disease. Pros and cons. Brain, Behavior, & Immunity - Health. 2025;50:101149. doi:10.1016/j.bbih.2025.101149
BibTeX
@article{Stepanova2025,
author = {Stepanova, Polina and Voutilainen, Merja H and Eriksson, Ove and Lindholm, Dan},
title = {Animal models of Huntington's disease. Pros and cons},
journal = {Brain, Behavior, & Immunity - Health},
year = {2025},
volume = {50},
pages = {101149},
doi = {10.1016/j.bbih.2025.101149}
}
EUVIMED